MD BEAUFAYS
ActiveSummary
MD BEAUFAYS has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €125,025 and a net result of €35,753. Equity grew by about 18% per year on average since 2018. In 2025 it fell by 27.7%. Its solvency ranks better than 65% of 22,817 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Official details
Source: KBO- Status
- Active since 13-11-2015 Normal situation
- Activity
- Retail sale of prescription glasses, lenses and sunglasses NACE 47742
- Joint committee
- 201 Independent retail · annual accounts 2025
- Establishment unit
- 2.251.538.561 4052 Chaudfontaine, since 01-08-2016
- Financial year end
- 31 December
- Peppol
- Reachable since 11-07-2025
Board and ownership
- ODL ManagementDirector · since 02-01-2023 · permanent representative Dylan LECLERC
- LECLERC DYLAN Terry Guyall the sharesdeed of 03-10-2023
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.2%
- Gross margin
- €86,437
- ▲ 8.6%
- Turnover
- ≈ €420,000
- estimated
- Profit
- €35,753
- ▲ 43.1%
- Equity
- €125,025
- ▼ 27.7%
- Total assets
- €249,977
- ▲ 17.5%
- Employees on 31-12-2025
- 1
- =
- 2025 accounts filed 28 days after the deadline
Score breakdownraises riskSector: Retail trade (NACE 47)Size: total assets €249,977lowers riskLiquidity: current ratio 1.91, cash €33,567Equity €125,025 (50.0% of total assets)Show the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 64% of them on solvency, 41% on liquidity, 81% on profitability and 17% on growth.
The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 23 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.
Searched, nothing found (2)
Key points
Recent changes
- · Gazette deed Legal-form change · Resignations & appointmentsFounding capital of €18,600, 100 shares · LECLERC DYLAN Terry Guy holds all the shares
- · Gazette deed 1 director appointed, 1 director resigningResignation: Dylan LECLERC (director) · Appointment: ODL Management (director) · Permanent representative: Dylan LECLERC
- · Gazette deed Incorporation
Comparable companies
These companies have the same main activity as MD BEAUFAYS: retail sale of prescription glasses, lenses and sunglasses (NACE 47742). They are comparable in size and age: total assets between €199,000 and €293,000, founded between 2013 and 2017.
| Company | Total assets | Gross margin |
|---|---|---|
| MD BEAUFAYS Chaudfontaine | €249,977 | €86,437 |
| Optiek Meuwes Wevelgem | €226,694 | €96,560 |
| OPTIEK AADMI Antwerp | €254,555 | €70,533 |
| LALOU Wuustwezel | €277,917 | €78,035 |
| SOMA & MORE Maldegem | €199,344 | €83,329 |
| BRIL DE PANNE De Panne | €225,666 | €68,534 |
| DELTIN Menen | €292,877 | €77,421 |
Key facts about MD BEAUFAYS
- What is the company number of MD BEAUFAYS?
- The company number of MD BEAUFAYS is 0642.880.465. The VAT number is the same number with BE in front: BE 0642.880.465.
- Where is MD BEAUFAYS based?
- The registered office is at Voie de l'Air Pur 240, 4052 Chaudfontaine.Company details
- What does MD BEAUFAYS do?
- According to the KBO register, the main activity is retail sale of prescription glasses, lenses and sunglasses (NACE 47742).
- What is the legal form of MD BEAUFAYS?
- MD BEAUFAYS is a private limited company (BV).
- When was MD BEAUFAYS founded?
- MD BEAUFAYS was founded on 13-11-2015.
- Is MD BEAUFAYS still active?
- Yes, MD BEAUFAYS is an active enterprise in the KBO register.
- How many employees does MD BEAUFAYS have?
- MD BEAUFAYS had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- Which joint committee does MD BEAUFAYS fall under?
- In its 2025 annual accounts, MD BEAUFAYS states joint committee 201 (Independent retail).
- What is the turnover of MD BEAUFAYS?
- The turnover in financial year 2025 is ≈ €420,000. This figure is estimated from the gross margin of €86,437 and 44 comparable companies (NACE 477). It probably lies between €220,000 and €570,000.
- Is MD BEAUFAYS profitable?
- In financial year 2025, MD BEAUFAYS made a profit of €35,753.
- Where can I find the annual accounts of MD BEAUFAYS?
- MD BEAUFAYS filed 10 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of MD BEAUFAYS due?
- MD BEAUFAYS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.